American Veterinary Medical Association
FDARulemakingFDA-2006-N-0239

Index of Legally Marketed Unapproved New Animal Drugs for Minor Species

RIN
Last modified
May 15, 2024
Comment window
closed 7160d ago
American Veterinary Medical Association filings
3

Activity

American Veterinary Medical Association filed 3 comments on this docket between Dec 15, 2015 and Dec 15, 2015. 1 other organizations filed here. The comment window closed 7160d ago.

What American Veterinary Medical Association filed (3)

Dec 15, 2015· Comment from American Veterinary Medical Association· FDA-2006-N-0239-0008

Filed on regulations.gov — full text not in the inline record.

Dec 15, 2015· Comment from American Veterinary Medical Association· FDA-2006-N-0239-0018

Filed on regulations.gov — full text not in the inline record.

Dec 15, 2015· Comment from American Veterinary Medical Association (AVMA)· FDA-2006-N-0239-0019

Filed on regulations.gov — full text not in the inline record.

Abstract

The Minor Use and Minor Species Animal Health Act of 2004 (MUMS act) amended the Federal Food, Drug, and Cosmetic Act (the act) to authorize the U.S . Food and Drug Administration (FDA, the agency) to establish new regulatory procedures that provide incentives intended to make more drugs legally available to veterinarians and animal owners for the treatment of minor animal species and uncommon diseases in major animal species . At this time, FDA is issuing proposed regulations to implement section 572 of the act entitled "Index of Legally Marketed Unapproved New Animal Drugs for Minor Species ." These regulations propose administrative procedures and criteria for index listing a new animal drug for use in a minor species. Such indexing provides a basis for legally marketing an unapproved new animal drug intended for use in a minor species .

View on regulations.gov →